General Announcement::ANNOUNCEMENT OF RESULTS OF THE REPURCHASE AS AT THE EXPIRATION TIME

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Oct-2018 12:50:23
Status
New
Announcement Sub Title
ANNOUNCEMENT OF RESULTS OF THE REPURCHASE AS AT THE EXPIRATION TIME
Announcement Reference
SG181003OTHRUIL1
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary Compliance Officer
Effective Date and Time of the event
03/10/2018 10:00:00
Description (Please provide a detailed description of the event in the box below)
SUB: ANNOUNCEMENT OF RESULTS OF THE REPURCHASE AS AT THE EXPIRATION TIME IN RESPECT OF THE COMPANY S U.S.$200,000,000 2.00 PER CENT. RESETTABLE ONWARD STARTING EQUITY-LINKED SECURITIES DUE 2022

With respect to the above subject, please find enclosed herewith Announcement of Results of the Repurchase.

You are requested to take the same on record.

Attachments

SGX_Intimation_03102018.pdf
Total size =239K